AI-Designed Viruses Treat Patient
3.6 Science And Tech, 2026-10-21
Radical Numerics announced the first use of A.I.-designed phages to treat a human patient with a resistant E. coli infection; the trial was authorized by the Food and Drug Administration. The company's model Omnii redesigned the legs of phage T7. In 2025, Arc Institute's Evo 2 generated 700,000 genomes, of which 285 were synthesized and 16 gave viable viruses. The technical report is not peer reviewed. Phage therapy dates back over a century and is revived by antibiotic resistance.